Collaboration Agreements

1,857 Contracts & Agreements

Collaboration agreements include contracts that define joint initiatives between a company and other parties.

Browse Collaboration Agreements by Industry

Aerospace & Defense (1 contract from 1 company)
Air Freight & Logistics (2 | 1)
Auto Components (2 | 1)
Automobiles (1 | 1)
Biotechnology (1,119 | 287)
Chemicals (8 | 3)
Communications Equipment (2 | 1)
Construction & Engineering (1 | 1)
Consumer Finance (5 | 2)
Diversified Consumer Services (4 | 3)
Electrical Equipment (21 | 5)
Electronic Equipment, Instruments & Components (5 | 1)
Energy Equipment & Services (4 | 3)
Entertainment (3 | 2)
ETFs (9 | 2)
Food Products (1 | 1)
Health Care Equipment & Supplies (101 | 37)
Health Care Providers & Services (7 | 6)
Health Care Technology (4 | 3)
Hotels, Restaurants & Leisure (1 | 1)
Household Durables (3 | 1)
Household Products (1 | 1)
Independent Power & Renewable Electricity Producers (1 | 1)
Interactive Media & Services (1 | 1)
Life Sciences Tools & Services (24 | 12)
Machinery (1 | 1)
Media (1 | 1)
Metals & Mining (6 | 3)
Oil, Gas & Consumable Fuels (4 | 3)
Personal Products (2 | 1)
Pharmaceuticals (230 | 114)
Semiconductors & Semiconductor Equipment (8 | 5)
Software (4 | 4)
SPACs, Investment, & Acquisition Companies (11 | 5)
Specialty Retail (1 | 1)
Unassigned Industry (258 | 117)

Recent Contracts

Form of Research Collaboration and License Agreement with Giiant Pharma (Neuralstem, Inc., Filed With SEC on September 8, 2023)
Collaboration Agreement by and among the Registrant, Shopify Inc., Shopify International Limited, Shopify Commerce Singapore PTE. LTD., and Shopify Strategic Holdings 3 LLC, dated... (Klaviyo, Inc., Filed With SEC on August 25, 2023)
Research Collaboration and License Agreement, dated September 10, 2021, by and between the Registrant and Amgen Inc (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Research Collaboration and License Agreement, dated February 8, 2021, by and between the Registrant and Nimble Therapeutics, Inc., as amended (RayzeBio, Inc., Filed With SEC on August 24, 2023)
License and Research Collaboration Agreement, dated August 4, 2020, by and between the Registrant and PeptiDream, Inc., as amended (RayzeBio, Inc., Filed With SEC on August 24, 2023)
The Collaboration Agreement dated August 14, 2023 (American BriVision (Holding) Corp, Filed With SEC on August 17, 2023)
Master Framework Agreement for Ethanol to Jet Collaboration, dated September 22, 2021, by and between Axens North America, Inc. and Gevo, Inc (Gevo, Inc., Filed With SEC on August 10, 2023)
Amended and Restated Exclusive Preferred Partner, Co-Promotion, Development Collaboration and License Agreement by and between Sanofi US Services, Inc. and DarioHealth Corp.,... (DarioHealth Corp., Filed With SEC on August 10, 2023)
Amendment No. 4 to Clinical Trial Collaboration and Supply Agreement (Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (IDEAYA Biosciences, Inc., Filed With SEC on August 10, 2023)
Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement (Second Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (IDEAYA Biosciences, Inc., Filed With SEC on August 10, 2023)
Collaboration Agreement by and between the Registrant and Amgen, Inc., dated as of May 8, 2023 (TScan Therapeutics, Inc., Filed With SEC on August 10, 2023)
Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Equillium, Inc., Filed With SEC on August 9, 2023)
Fourth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 12, 2023 (Repare Therapeutics Inc., Filed With SEC on August 9, 2023)
Amendment No. 3 dated April 27, 2023 to the Collaboration and License Agreement by and between the Registrant and BicycleTx Limited dated July 9, 2021. Portions of this exhibit... (IONIS PHARMACEUTICALS INC, Filed With SEC on August 9, 2023)
Letter Agreement dated June 29, 2023 in reference to the Collaboration and License Agreement dated December 6, 2021 by and between Akcea Therapeutics, Inc. and AstraZeneca AB.... (IONIS PHARMACEUTICALS INC, Filed With SEC on August 9, 2023)
Amendment No. 3 to the Collaboration and License Agreement, dated as of May 18, 2023, by and between CytomX Therapeutics, Inc. and Amgen, Inc (CytomX Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amendment No. AR4 to Amended and Restated Collaboration and License Agreement, by and between the Registrant and D.E. Shaw Research, LLC, dated March 22, 2023 (Relay Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amendment No. 2 to the Option, License and Collaboration Agreement, dated May 15, 2023, between Arcus Biosciences, Inc. and Gilead Sciences, Inc (Arcus Biosciences, Inc., Filed With SEC on August 7, 2023)
Amendment No. 13 to Collaboration and License Agreement, effective as of May 16, 2023, between Ultragenyx Pharmaceutical Inc. and Kyowa Kirin, Co., Ltd (Ultragenyx Pharmaceutical Inc., Filed With SEC on August 4, 2023)
First Amendment to Collaboration and License Agreement, dated January 30, 2023, by and between the Company and Janssen Biotech, Inc (Xencor Inc, Filed With SEC on August 3, 2023)
Letter Agreement Amending the 2021 Collaboration and License Agreement between the Registrant and Glaxo Wellcome UK Ltd. dated May 19, 2023 (Alector, Inc., Filed With SEC on August 3, 2023)
First Amendment to Collaboration and License Agreement, effective as of April 20, 2023, by and between the Registrant and MyoKardia, Inc., a wholly-owned subsidiary of Bristol... (Fulcrum Therapeutics, Inc., Filed With SEC on August 3, 2023)
First Amendment to Amended and Restated License and Collaboration Agreement by and between the Registrant and Aventis Pharmaceuticals Inc., dated May 1, 2013 (Regeneron Pharmaceuticals, Filed With SEC on August 3, 2023)
Amendment No. 1 to Collaboration and License Agreement, dated as of June 5, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant... (Blueprint Medicines Corp, Filed With SEC on August 2, 2023)
Amendment No. 2 to Collaboration and License Agreement, dated as of July 27, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant... (Blueprint Medicines Corp, Filed With SEC on August 2, 2023)
Collaboration Agreement dated as of July 19, 2023, by and between Treasure Global Inc and VCI Global Limited (TREASURE GLOBAL INC, Filed With SEC on July 21, 2023)
Master Collaboration Agreement, dated November 1, 2021, between MIRA Pharmaceuticals, Inc. and The Johns Hopkins University (MIRA PHARMACEUTICALS, INC., Filed With SEC on July 14, 2023)
Research and Development Collaboration and License Agreement by and between the Company and Applied Biomedical Science Institute dated July 5, 2023 (Hillstream BioPharma Inc., Filed With SEC on July 11, 2023)
Electronics Collaboration Agreement, dated July 2, 2023, by and between BorgWarner PDS (USA) Inc. and PHINIA Technologies Inc (PHINIA INC., Filed With SEC on July 7, 2023)
License and Collaboration Agreement, executed and delivered as of June 19, 2023, by and between Santhera, its wholly-owned subsidiary, Santhera Pharmaceuticals (Schweiz) AG, and... (CATALYST PHARMACEUTICALS, INC., Filed With SEC on June 23, 2023)
Second Amendment to Collaboration Agreement, dated June 15, 2023, among SomaLogic, Inc., Illumina Cambridge, Ltd. and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on June 22, 2023)
Supply and Collaboration Agreement dated as of June 19, 2023 by and between the Company and DaVita Inc (CHF Solutions, Inc., Filed With SEC on June 21, 2023)
Amended and Restated Master Collaboration Agreement, dated January 1, 2021, between Turnstone Biologics Corp. and H. Lee Moffitt Cancer Center and Research Institute, Inc (Turnstone Biologics Corp., Filed With SEC on June 12, 2023)
Collaboration& Engineering Services Agreement, dated as of September15, 2022, by and between Textron Aviation Inc. and Surf Air Mobility Inc (SURF AIR MOBILITY INC., Filed With SEC on June 5, 2023)
Amended Collaboration & Engineering Services Agreement, dated as of May 24, 2023, by and between Textron Aviation Inc. and Surf Air Mobility Inc (SURF AIR MOBILITY INC., Filed With SEC on June 5, 2023)
License and Collaboration Agreement, dated (C4 Therapeutics, Inc., Filed With SEC on May 30, 2023)
Collaboration Agreement by and between JD E-commerce American Limited and Maison Solutions Inc. dated April 19, 2021 (English Translation) (Maison Solutions Inc., Filed With SEC on May 22, 2023)
Amended and Restated License and Collaboration Agreement, dated May 15, 2023, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited (Zymeworks Delaware Inc., Filed With SEC on May 16, 2023)
Collaboration Agreement, dated August 10, 2020, by and between Adimab, LLC and Flame Biosciences, Inc (LEAP THERAPEUTICS, INC., Filed With SEC on May 15, 2023)
Collaboration and Revenue-Sharing Agreement between Signing Day Sports, Inc. and Louisville Slugger Hitting Science Center LLC, dated as of October 31, 2022 (Signing Day Sports, Inc., Filed With SEC on May 15, 2023)